Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-10 | Jeffrey M. Leiden, M.D., Ph.D., 59, has been Chairman, President and CEO of Vertex Pharmaceuticals Incorporated since 2011. ... Dr. Leiden has been a director of Quest Diagnostics since December 2014. He has extensive executive and advisory experience, including in general management and strategic planning, with a range of health care organizations, and extensive experience with healthcare issues and the operation of the U.S. healthcare system, including as a practicing physician. |
| 2016-04-07 | Jeffrey M. Leiden, M.D., Ph.D. 60 2014 Chairman, President and CEO, Vertex Pharmaceuticals Incorporated CC QSC 240,180 |
| 2017-04-05 | Dr. Leiden has been Chairman, President and CEO of Vertex Pharmaceuticals Incorporated since 2011. ... Dr. Leiden has extensive executive and advisory experience, including in general management and strategic planning, with a range of health care organizations, and extensive experience with healthcare issues and the operation of the U.S. healthcare system, including as a practicing physician. ... Compensation Committee: Timothy M. Ring (Chair), John C. Baldwin*, Vicky B. Gregg, Jeffrey M. Leiden, Gail R. Wilensky ... Quality, Safety and Compliance Committee: Gail R. Wilensky (Chair), John C. Baldwin*, Jenne K. Britell, Vicky B. Gregg, Jeffrey M. Leiden, John B. Ziegler ... 2016 Directors Compensation Table: Jeffrey M. Leiden 281,075 |
| 2018-04-04 | Dr. Leiden has been Chairman, President and CEO of Vertex Pharmaceuticals Incorporated since 2011. ... Compensation Committee: Jeffrey M. Leiden Number of 2017 Meetings: 4 ... 2017 Director Compensation Table: Jeffrey M. Leiden Fees Earned or Paid in Cash ($) 113,000 Stock Awards ($) 167,965 Total ($) 280,965 |
Data sourced from SEC filings. Last updated: 2026-03-05